2014 Summit Faculty interview with Louis Kuritzky, MD, about some of the benefits and risks of statin treatment, including the risk of developing diabetes.
Co-Chair Edward Shahady, MD, FAAFP, ABCL, interviews Kevin Peterson, MD, MPH, on what happens to Beta Cells after 3 years of GLP-1 administration, compared with insulin.
In this video, Margo Minissian, PhD, ACNP, speaks about cholesterol management guidelines, including managing patients with statin myalgia and patients at risk for polypharmacy, and strategies for LDL...
In this video, Raymond Cross, MD, from the University of Maryland, addresses the most challenging extraintestinal manifestations among patients with inflammatory bowel disease.
